Furthermore, nectin-2 also has the potential to be a prognostic and diagnostic marker in cancers such as gallbladder cancer, pancreatic cancer, oesophageal cancer, breast cancer, and acute myeloid leukemia. This evidence concerns the gene NECTIN2 and gallbladder cancer.